Free Stock Tips

Hi Everybody,

Our alert for Wednesday looks amazing. We think we found a real gem here, the stock appears to be extremely undervalued based on recent news and traders taking positions at these levels will see tremendous upside.

Highlights:
• This company is a medical device company with FDA approved products.
• The US government passed legislation that should drive sales.
• This company is a potential takeover candidate.

Our alert for Wednesday is:
VeriTeQ Corporation
Ticker symbol: VTEQD
Last price: $0.03

VTEQD develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment.

VTEQD has proprietary technology, including over 100 patents, patents pending, patent licenses, and U.S. Food and Drug Administration cleared and CE marked products.

VTEQD has two principal business lines:
1. Unique Device Identification (UDI) for medical devices
2. Radiation dosimeters and other medical sensor applications.

What’s most interesting is their UDI technology. Branded as Q Inside Safety Technology, these little RFID chips VTEQD produces are placed in medical products such as breast implants.

One major issue this helps resolve is when there is a recall. Without the RFID tech, when there is a recall on a certain line of implants there’s no real way of knowing if someone’s implant should be recalled. With VTEQD’s UDI technology this will no longer be an issue.

Not only does it solve this problem, this kind of UDI technology is now being mandated by the FDA for reusable devices such as implant ‘sizers’.

In September 2013 FDA issued a Final Rule (“Rule”) which will require most medical devices sold in the U.S. to carry a UDI.

Now here’s where it gets interesting…

VeriTeQ Corporation executes term sheet for exclusive license of its Q Inside Safety Technology for the breast implant market with a $1.75 million up front payment.

VTEQD’s market cap is 42K. Can you say ‘undervalued’?

Not to mention, 80% of the breast implant market is controlled by Mentor and Allergen. Given the FDA requirements, and the cost of developing a technology like VTEQD’s, it would stand to reason that these two giants may take a long look at VTEQD as a possible acquisition.

All of these factors along with the fact the stock is only 3 cents a share make VTEQD a very intriguing opportunity. As more investors learn about this story the rush could create some huge price appreciation relatively quickly.

Make sure you’re ready to book your profits with VTEQD.

As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading